SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001175707-23-000068
Filing Date
2023-02-14
Accepted
2023-02-14 10:45:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 13ga1_silence.htm SC 13G/A 49736
  Complete submission text file 0001175707-23-000068.txt   51178
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Subject) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A | Act: 34 | File No.: 005-92205 | Film No.: 23624277
SIC: 2834 Pharmaceutical Preparations

Mailing Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018
Business Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

IRS No.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A